A severe COVID-19 disease that increases the risk of bacterial and fungal infections is associated with decreased expression of CD4 interferon-gamma, lower counts of CD4 and CD8 cells, and an increase in proinflammatory cytokines such as IL-1, IL-6, and tumor necrosis alpha, leading to higher chances of mucormycosis [3]. Here, CD4 is linked to fungal infectious disease.